Novartis Institutes for Biomedical Research

Venture Capital

NIBR occasionally takes minority equity stakes in biotech companies whose science complements Novartis's drug-discovery pipeline, such as its 7.3% stake in Homology Medicines alongside co-investors 5AM Ventures and Arch Venture Partners. It is Novartis's global R&D engine, with about 6,000 scientists worldwide.

Cambridge · 1+ investments · 1 portfolio companies

Biotech
Headquarters
Cambridge
Founded
2002
Portfolio Company
1
Total Investment
1
Last Investment
Jun 2016

Indexed holds 1 portfolio company and 1 funding round for this investor. The full record is or through the API.

Investment Thesis

NIBR takes minority equity stakes in biotech companies whose science complements its internal drug-discovery pipeline, often investing alongside established venture capital co-investors.

Novartis Institutes for Biomedical Research is a Venture Capital firm based in Cambridge. It has made 1 investment, including Blade Therapeutics. Focus areas include Biotech.

Portfolio1

Co-investors5

Sign up to view co-investors

5 co-investors across 5 shared portfolio companies — who they back alongside, and how often they lead.

Venture Capital ×4 · Corporate VC ×1 · 5 shared rounds

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

Novartis Institutes for Biomedical Research on Indexed.vc
<a href="https://indexed.vc/investors/novartis-institutes-for-biomedical-research"><img src="https://indexed.vc/api/badge/investor/novartis-institutes-for-biomedical-research" alt="Novartis Institutes for Biomedical Research on Indexed.vc" width="260" height="76" /></a>